HIV-1 Tat is considered to be one of key players to facilitate monocyte entry into the CNS, which is characteristic feature of AIDS-related encephalitis and dementia. This study was performed to determine the regulatory function of superoxide dismutase (SOD) on the HIV-1 Tat 
Introduction
AIDS dementia complex (ADC) is a neurological disorder associated with HIV infection and affects up to 50% of adult AIDS patients. One of the characteristic features of ADC is the infiltration of monocytes into the CNS which represents one of the early steps to inflammatory events within the CNS (Ozdener, 2005; Rumbaugh and Nath, 2006) . Considerable evidences suggest that abnormal expression of cell adhesion molecules and cytokine dysregulation mediate entry of monocytes into the CNS (Weiss et al., 1999; Pu et al., 2003; D'Aversa et al., 2004) .
HIV-1 Tat (transactivator of transcription) protein, which can be secreted from the infected cells, has the ability to enter uninfected cells and exert its activity on the expression of various adhesion molecules including vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) in human endothelial cells and astrocytes (Dhawan et al., 1997; Woodman et al., 1999; Song et al., 2007) . Up-regulation of expression of adhesion molecules such as ICAM-1 and VCAM-1 by HIV-1 Tat may induce a series of interactions between monocytes, endothelial cells, and astrocytes, facilitating infiltration of monocytes into the CNS (Rappaport et al., 1999; Langford and Masliah, 2001) . Therefore, HIV-1 Tat may be an important regulator in the trafficking of monocytes into the CNS which may contribute to the development of HIV-associated pathologies including ADC (Rappaport et al., 1999) .
Stimulation of astrocytes with HIV-1 Tat resulted in activation of NF-κB which was responsible for up-regulation of various cytokines, chemokines and adhesion molecules (Nicolini et al., 2001; Song et al., 2007) . Although the mechanisms of Tat-mediated NF-κB activation remain to be elucidated, several studies have implicated the in-volvement of Tat-induced oxidative stress (Bruce- Keller et al., 2001; Song et al., 2007) . HIV-1 Tat can increase levels of reactive oxygen species (ROS) directly and indirectly which in turn activates NF-κB, a redox-sensitive transcriptional factor. ROS such as superoxide anion (O2 ) and hydrogen peroxide (H 2 O 2 ) can act as second messengers in the intracellular signaling pathways involved in expression of many proinflammatory genes (SchulzeOsthoff et al., 1997; Brenneisen et al., 2002) .
In the previous study, we showed that ROS generated by HIV-1 Tat mediates NF-κB activation, up-regulation of ICAM-1 and VCAM-1 and subsequent increased monocyte adhesion to astrocytes by using various antioxidants (Song et al., 2007) . These results suggest that prevention of ROS generation upon Tat stimulation is one of strategies to control Tat-induced monocyte infiltration into the CNS. Although previous studies have demonstrated that several antioxidants can inhibit NF-κB activation by HIV-1 Tat, suggesting the involvement of ROS, the molecular mechanisms by which HIV-1 Tat mediates NF-κB activation are poorly understood. Due to broad effects of antioxidants on cellular physiology, it would be difficult to study the exact role of ROS in HIV-1 Tat induced NF-κB activation. Therefore, in this study, we explored the role of ROS generation in HIV-1 Tat-induced NF-κB activation and resulting enhanced adhesiveness of monocyte to astrocyte by using cell-permeable PEP-1-SOD. PEP-1-SOD has been shown to exert a protective effect against oxidative stress in various cell types and in vivo disease models (Eum et al., 2004; Choi et al., 2006) . We report herein that SOD has a regulatory function for HIV-1 Tat-induced NF-κB activation, up-regulation of ICAM-1/VCAM-1 and increased monocyte adhesion to astrocytes.
Materials and Methods

Cell culture
CRT-MG human astroglial cells and THP-1 human monocytic cells were maintained in RPMI 1640 medium supplemented with 10% (v/v) heat-inactivated FBS, penicillin G (100 U/ml), streptomycin (100 µg/ml) and L-glutamine (2 mM) at 37 o C in a humidified atmosphere containing 5% CO2 and 95% air (Choi et al., 2002; Park et al., 2003) .
Reagents
Calcein acetoxymethyl ester (calcein-AM) was purchased from Molecular Probe (Eugene, OR). Primary antibodies against ICAM-1, VCAM-1, actin and p65 (Santa Cruz, CA), and phosphor-p38, phosphor-ERK, or phosphor-JNK, total-p38 MAPK, total-ERK, and total-JNK (Cell Signaling Technology, Beverly, MA) were obtained commercially. HRP-conjugated anti-rabbit or goat antibodies were supplied by Sigma (St. Louis, MO).
Purification of recombinant HIV-1 Tat protein
Recombinant HIV-1 Tat protein was purified under native conditions as described previously (Song et al., 2007) . Endotoxin levels for the Tat preparation were below the detection limit (＜0.1 EU/ml) as tested by Limulus Amoebocyte Lysate assay (BioWhitaker, Walkersville, MD). The integrity and purity of the HIV-1 Tat proteins were assessed by SDS-PAGE followed by Coomassie blue staining. The biological activity of Tat was confirmed by a transactivation assay in HeLa cells transfected with a plasmid containing an HIV LTR-luciferase gene.
Expression and purification of PEP-1-SOD fusion proteins
PEP-1-SOD expression vector was constructed to express the PEP-1 peptides (KETWWETWWTE-WSQPKKKRKV) as a fusion with human Cu, Zn-SOD. Expression and purification of SOD fusion proteins were carried out as described previously (Eum et al., 2004; Choi et al., 2006) . SOD fusion proteins were expressed by inducing E. coli BL21 cells transformed with plasmids encoding the SOD or PEP-1-SOD fusion proteins with IPTG. To prepare SOD fusion proteins, the induced cells were pelleted and lysed in a binding buffer (5 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 7.9). The fusion proteins were purified by affinity chromatography on a Ni 2+ -IDA column, followed by desalting with a PD10 column (Amersham). The purified SOD fusion proteins dissolved in PBS containing 20% glycerol were then aliquoted and stored at 80 o C.
Western blot analysis
Cell lysates were prepared by incubating cells in lysis buffer (125 mM Tris-HCl pH 6.8, 2% SDS, 10% v/v glycerol) at 4 o C for 30 min. Samples of fifty µg protein were separated on a 10% SDSpolyacrylamide gel and the proteins electrotransferred to a nitrocellulose membrane, which was blocked with 10% dry milk in PBS. The membrane was probed with the indicated antibodies, and the immunoreactive bands were visualized by enhanced chemiluminescence (ECL; Amersham) as recommended by the manufacturer.
RT-PCR analysis
Total RNA was isolated from CRT-MG cells using a Trizol reagent kit (Invitrogen, Gaithersburg, MD) according to the manufacturer's instructions (Zhang et al., 2005) . The RNA (2 µg) was reversibly transcribed with 10,000 U of reverse transcriptase and 0.5 µg/µl oligo-(dT)15 primer (Promega, Madison, WI). PCR amplification of cDNA aliquots was performed with the following sense and antisense primers (5' → 3'): VCAM-1 sense, ATGCCT-GGGAAGATGGTCGTGA; VCAM-1 antisense, TGG-AGCTGGTAGACCCTCGTG; ICAM-1 sense, GGT-GACGCTGAATGGGGTTCC; ICAM-1 antisense, GTCCTCATGGTGGGGCTATGACTC; beta-actin sense, GCGGGAAATCGTGCGTGACATT; and betaactin antisense, GATGGAGTTGAAGGTAGTTTCGTG. PCR was performed in 50 µl of 10 mM Tris-HCl (pH 8.3), 25 mM MgCl2, 10 mM dNTP, 100 U of Taq DNA polymerase, and 0.1 µM of each primer and was terminated by heating at 70 o C for 15 min. PCR products were resolved on a 1% agarose gel and visualized with UV light after ethidium bromide.
Measurement of intracellular ROS
Intracellular ROS were measured using 2',7'-dichlorofluorescein diacetate (DCF-DA), which is converted by ROS into fluorescent 2',7'-dichlorofluorescein (DCF). CRT-MG cells (1 × 10 5 cells) were incubated in the absence or presence of PEP-1-SOD or SOD fusion proteins for 1 h, and then treated with HIV-1 Tat protein (500 ng/ml) for 15 min. Cells were washed twice with PBS and incubated with DCF-DA (10 µM) for 30 min. The cellular fluorescent images were obtained using a Zeiss Axiovert S100 microscope with a confocal laser-scanning system (Bio-Rad MRC-1024ES) as previously described . In a different set of experiments, intracellular superoxide generation was measured by using the conversion of nitroblue tetrazolium (NBT) to formazan according to a modified version of previously described method (Rook et al., 1985) . NBT can be reduced by superoxide anion via one-electron transfer reactions (Tarpey and Fridovich, 2001 ). CRT-MG cells were incubated in the absence or presence of SOD fusion proteins for 1 h, and then treated with HIV-1 Tat protein (500 ng/ml) for 15 min. Cells were washed twice with PBS and incubated with NBT (1 mg/ml) for 30 min. CRT-MG cells were lysed and formazan was dissolved with 2 M KOH and 1.4 volume of DMSO. The absorbance was read at 654 nm with a microplate reader.
NF-κB protein localization
The NF-κB p65 nuclear localization was detected by indirect immunofluorescence assay using confocal microscopy as described previously (Kim et al., 2003) . Briefly, CRT-MG cells grown on a glass slide in a 12-well plate were treated with HIV-1 Tat for 1 h. After being washed in PBS, the cells were fixed with 4% ice-cold formaldehyde for 30 min and permeablized with 0.2% Triton X-100. Rabbit polyclonal antibody to human NF-κB p65 (1:500) was applied for 1 h followed by incubation with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (1:500) for 1 h. The cells were transferred to a chamber on the stage of a Zeiss Axiovert S100 microscope and observed with a confocal laser-scanning system (Bio-Rad MRC-1024ES). The fluorescence images (excitation 494 nm/emission 518 nm) of the cells were recorded every 0.25 s (× 640). To determine NF-κB localization by Western blot analysis, nuclear protein extracts were prepared as described previously (Park et al., 2003 and analyzed with using anti-human NF-κB primary antibody (1:1,000).
Electrophoretic mobility shift assay (EMSA)
CRT-MG cells were treated with HIV-1 Tat (500 ng/ml) for 1 h, then nuclear extracts of CRT-MG cells were prepared and analyzed for NF-κB binding activity by EMSA as described previously (Park et al., 2003 ). An NF-κB consensus oligonucleotide (Promega) was used in the EMSA. The complementary oligonucleotide was annealed and end-labeled with [γ-32 P]ATP using T4 polynucleotide kinase. EMSA was performed in a total volume of 20 µl at 4 o C. Five micrograms of nuclear extracts were equilibrated for 15 min in binding buffer (10 mM Tris-HCl, pH 8.0, 75 mM KCl, 2.5 mM MgCl 2 , 0.1 mM EDTA, 10% glycerol, 0.25 mM DTT) and 1 µg of poly dI/dC. 32 P-labeled oligonucleotide probe (20,000 cpm) was then added and the reaction was incubated on ice for an additional 20 min. Bound and free DNA were then resolved by electrophoresis on a 6% native polyacrylamide gel in TBE buffer (89 mM Tris-HCl, 89 mM boric acid, and 2 mM EDTA).
Cell adhesion assay
Adherence of THP-1 cells to CRT-MG cells was assayed using a cell-cell adhesion assay as described elsewhere . Briefly, CRT-MG cells (7.0 × 10 4 ) were plated in 24-well glass chamber slide and exposed to HIV-1 Tat for 12 h. The calcein-AM labeled THP-1 (7.0 × 10 5 ) was co-cultured with CRT-MG cells for 1 h. Co- cultured cells were washed three times with PBS. The fluorescence images were obtained at 485 nm excitation and 538 nm emission using a SPOT II digital camera-attached fluorescence microscope with Spot II data acquisition software (Diagnostic Instrument). For the adhesion quantification, the calcein-AM fluorescent intensity was measured at 485 nm excitation and 538 nm emission by a Fluoroskan ELISA plate reader (Labsystems Oy).
Results
Delivery efficiency of SOD fusion proteins into astrocytes
PEP-1 peptide, which has 21 amino acid residues, is a known carrier peptide that delivers exogenous protein into living cells (Morris et al., 2001) . We have reported that the genetic in-frame PEP-1-superoxide dismutase (PEP-1-SOD) was efficiently delivered in vitro and in vivo and exerted its protective effect against oxidative stress (Eum et al., 2004; Choi et al., 2006) . To evaluate the cellular uptake of SOD fusion proteins into the human astrocytic cell line CRT-MG, SOD fusion proteins were added to cells at varying concentrations for 1 h, and the amounts of protein taken up were analyzed by Western blotting. As shown in Figure  1A , PEP-1-SOD efficiently entered the cells whereas the control SOD did not. Next, we analyzed the kinetics of incorporation of PEP-1-SOD ( Figure  1B ). As shown in Figure 1B , intracellular PEP-1-SOD increased in a time-dependent manner. To investigate the stability of PEP-1-SOD in the cells, PEP-1-SOD was added to cultured media and incubated for various time intervals. And then, the levels of SOD fusion proteins in the cells were analyzed by Western blotting. The amount of intracellular PEP-1-SOD was constant for 3 h, and then declined gradually ( Figure 1C ).
The effect of the introduced PEP-1-SOD on ROS generation induced by HIV-1 Tat
We previously reported that HIV-1 Tat can induce ROS generation in CRT-MG cells (Song et al., 2007) . To examine the effect of SOD on ROS generation induced by HIV-1 Tat, CRT-MG cells were pretreated with SOD fusion proteins for 1 h and then exposed to HIV-1 Tat (500 ng/ml) for 15 min and the levels of intracellular ROS was evaluated by DCF-DA staining ( Figure 2A ) and NBT assay ( Figure 2B ). Pre-treatment with PEP-1-SOD inhibited Tat-induced increase of intracellular ROS levels in CRT-MG cells whereas the control SOD had minimal effect (Figure 2A and B) . These results indicate that PEP-1-SOD can efficiently remove ROS generation by HIV-1 Tat stimulation in CRT-MG cells.
The effects of SOD on HIV-1 Tat-induced activation of NF-κB
NF-κB is one of redox-dependent transcription factors (Sen and Packer, 1996; Flohe et al., 1997) , and we previously reported that ROS was involved in Tat-induced activation of NF-κB in human astrocytes (Song et al., 2007) . Next, we examined the effect of SOD on Tat-induced nuclear translocation and DNA binding ability of NF-κB in CRT-MG cells. CRT-MG cells were incubated in the presence of SOD fusion proteins for 1 h, followed by exposure to HIV-1 Tat (500 ng/ml) for 1 h. Nuclear accumulation of NF-κB p65 in HIV-1 Tat treated CRT-MG cells were strongly induced. PEP-1-SOD prevented Tat-induced translocation of p65, as analyzed by fluorescence microscopy and Western blot technique ( Figure 3A and B) . In addition, pretreatment with PEP-1-SOD suppressed Tat-induced DNA binding activity of NF-κB ( Figure 3C ). 
Inhibition of HIV-1 Tat-induced MAPK activation by PEP-1-SOD in CRT-MG
The MAPK signaling cascades have been shown to be involved in activation of NF-κB upon HIV-1 Tat stimulation (Badou et al., 2000; Bruce-Keller et al., 2001; Liu et al., 2002 Liu et al., , 2005 . Several lines of evidence have indicated that ROS has a regulatory role in the activity of MAPKs such as p38, JNK and ERK protein kinase (Kyaw et al., 2004) . To examine the effect of SOD on HIV-1 Tat induced MAPK activation, CRT-MG cells were incubated in the absence or presence of PEP-1-SOD or SOD fusion protein for 1 h, followed by exposure to HIV-1 Tat (500 ng/ml) for 1 h, and then MAPK activation was analyzed by Western blot analysis (Figure 4) . PEP-1-SOD suppressed HIV-1 Tat-induced MAPK activation in a dose-dependent manner in CRT-MG cells.
Effects of SOD on HIV-1 Tat-induced expression of ICAM-1 and VCAM-1
ICAM-1 and VCAM-1 expression is regulated by different transcription factors including NF-κB in astrocytes (Lee et al., 1998) . We previously reported that ROS was involved in Tat-induced increase of ICAM-1 and VCAM-1 expression by human astrocytes (Song et al., 2007) . We further used these SOD fusion proteins to analyze the role of ROS on Tat-induced up-regulation of ICAM-1 and VCAM-1 expression in CRT-MG cells. Cells were incubated in the absence or presence of SOD fusion proteins for 1 h, treated with Tat (500 ng/ml), and then ICAM-1 and VCAM-1 expression were analyzed by RT-PCR and Western blot analysis. Pre-treatment with PEP-1-SOD inhibited markedly ICAM-1 and VCAM-1 mRNA ( Figure 5A ) and protein ( Figure 5B ) expression.
Effects of SOD on HIV-1 Tat-induced monocyte adhesion to astrocytes
To further confirm the relevance between ROS production and monocyte adhesion, we examined the effect of SOD on monocyte adhesion to CRT-MG cells. CRT-MG cells were incubated in the absence or presence of SOD fusion proteins for 1 h, treated with Tat (500 ng/ml), and then analyzed for monocyte adhesion to CRT-MG cells. As shown in Figure 6 , adhesion between THP-1 and CRT-MG cells induced by HIV-1 Tat decreased significantly when the CRT-MG cells were pre-treated with CRT-MG cells were treated with 0.5, 1 and 2 µM PEP-1-SOD or 2 µM SOD fusion proteins for 1 h, and then exposed to HIV-1 Tat protein (500 ng/ml) for 8 h. Total RNA was extracted. VCAM-1, ICAM-1 and β-actin mRNA were analyzed by RT-PCR using specific primers. (B) CRT-MG cells were treated with HIV-1 Tat protein (500 ng/ml) for 12 h with or without pretreatment with PEP-1-SOD or SOD fusion protein for 1 h. Cell extracts were prepared and analyzed by Western blotting for VCAM-1 and ICAM-1 protein expression. TNF-α (10 ng/ml) was used as a positive control. CRT-MG cells were treated with HIV-1 Tat protein (500 ng/ml) for 1 h with or without pretreatment with the PEP-1-SOD or SOD fusion proteins. NF-κB nuclear localization was visualized with a confocal microscopy by indirect immunofluorescence using anti-NF-κB p65 antibody (A). Nuclear extracts were prepared from the CRT-MG cells treated with HIV-1 Tat and the levels of p65 were determined by Western blot analysis (B). DNA-binding activity of NF-κB in the nuclear extracts of the CRT-MG cells was measured by EMSA (C). PEP-1-SOD ( Figure 6A and B) . These results indicate that ROS is required for Tat-induced expression of ICAM-1 and VCAM-1 and subsequent adheson of monocyte to astrocytes.
Discussion
HIV-1 Tat can induce upregulation of adhesion molecules and cytokine/chemokine dysregulation which may induce a series of interactions between monocytes, endothelial cells, and astrocytes, resulting in enhanced infiltration of monocytes into the CNS (Rappaport et al., 1999; Langford and Masliah, 2001 ). Upon HIV-1 Tat stimulation, astrocytes can express the increased level of adhesion molecules such as ICAM-1 and VCAM-1, which lead to monocyte entry into the CNS (Rappaport et al., 1999; Pu et al., 2003) . Previous studies demonstrated that intracerebral administration of HIV-1 Tat in mouse induced expression of adhesion molecules, such as ICAM-1 and VCAM-1, leading to monocyte infiltration which induced profound proinflammatory effects in the brain, suggesting that HIV-1 Tat alone can markedly contribute to the development of ADC in HIV-1-infected patients (Pu et al., 2003) . We previously reported that HIV-1 Tat can modulate monocyte adhesiveness by increasing expression of adhesion molecules such as ICAM-1 and VCAM-1 via ROS-and NF-κB-dependent mechanisms in astrocytes (Song et al., 2007) . Further understanding of the role of ROS generation in Tat mediated infiltration of monocyte into the CNS might help to develop a therapeutic tool for ADC. In this study, we examined the effect of superoxide dismutase on HIV-1 Tat-induced expression of adhesion molecules such as ICAM-1 and VCAM-1, and subsequent monocyte adhesion by astrocyte. We show that SOD suppressed HIV-1 Tat-induced ROS generation, activation of NF-κB and subsequent expression of adhesion molecules and monocyte adhesion in human astrocytes.
Since ROS plays a major role in a variety of neurodegenerative and neuroinflammatory diseases such as Alzheimer's disease (Keller et al., 1999; Wang and Joseph, 1999) , there have been considerable efforts in the use of anti-oxidant enzymes in protection against ROS-mediated diseases (Greenwald, 1990) . Recombinant enzymes such as SOD and catalase have been used to protect against oxidative stresses. We generated a cell permeable SOD, PEP-1-SOD, by use of a peptide that is capable of delivering protein into cells. Cell-permeable SOD has been shown to be beneficial in several oxidative stress models such as ischemia, Parkinson disease, and diabetes (Eum et al., 2004; Choi et al., 2006) . Previous studies have shown by using various anti-oxidants that HIV-1 Tat induced ROS mediates various cellular functions such as NF-κB activation, MAPK activation, and expression of proinflammatory molecules including adhesion molecules. However, broad effects of anti-oxidants on the cellular functions hampers to study the exact role of ROS in HIV-1 Tat induced cellular dysregulation such as NF-κB activation. We have previously shown that expression of ICAM-1 and VCAM-1 was up-regulated at the transcriptional level via ROS-and NF-κB-dependent pathways upon HIV-1 Tat stimulation (Song et al., 2007) . HIV-1 Tat-induced NF-κB activation was signifi-cantly inhibited in cells treated with HIV-1 Tat in the presence of PEP-1-SOD (Figure 3) , indicating the functional consequence of ROS generation by Tat. Treatment of CRT-MG cells with PEP-1-SOD before exposure to HIV-1 Tat significantly inhibited activation of MAPKs such as ERK, JNK and p38. Furthermore, application of PEP-1-SOD significantly suppressed HIV-1 Tat induced upregulation of ICAM-1/VCAM-1 expression and subsequent enhanced monocyte adhesion to astrocyte. These results indicate that ROS is involved in the signaling pathway leading to activation of NF-κB and to expression of NF-κB-responsive genes such as ICAM-1 and VCAM-1 in astrocytes. In addition, theses results demonstrate that the PEP-1-SOD has anti-oxidant and anti-inflammatory activities.
In consistent with our results, several reports have indicated that SOD has a regulatory role in proinflammatory responses. Stable overexpression of SOD attenuated significantly LPS-induced activation of NF-κB and release of cytokines such as TNF-α and IL-6 in microglial cells (Dimayuga et al., 2007) . In addition, SOD overexpression mediated by adenoviral vector effectively inhibited activation of NF-κB and expression of adhesion molecules such as ICAM-1/VCAM-1 upon TNF-α stimulation in human endothelial cells (Lin et al., 2005) . Taken together, these studies suggest that SOD has anti-inflammatory activities and may play important roles in modulating ROS-dependent signaling pathways and inflammation response.
Although the exact sources of ROS generation induced by HIV-1 Tat in astrocyte have not been elucidated, inhibition of HIV-1 Tat-induced generation of ROS by DPI, suggests the involvement of a NADPH oxidase (Song et al., 2007) . We are studying the possible role of NOX family in Tatinduced NF-κB activation to define the exact molecular source of ROS generation upon HIV-1 Tat stimulation.
In conclusion, the inhibitory activity of PEP-1-SOD in Tat-mediated adhesion molecule expression and subsequent increased adhesion of monocyte to astrocyte implicates that SOD has a regulatory function in the HIV-1 Tat-induced signaling pathways leading to NF-κB activation. PEP-1-SOD has been shown to be beneficial in several oxidative stress models such as ischemia and Parkinson's disease (Eum et al., 2004; Choi et al., 2006) . Cell-permeable SOD can be used as a therapeutic agent against Tat-induced ROS-associated neurotoxicity.
